Loading...
XJPX3649
Market cap148mUSD
Jan 15, Last price  
902.00JPY
1D
2.85%
1Q
6.24%
Jan 2017
-4.85%
IPO
982.44%
Name

Findex Inc

Chart & Performance

D1W1MN
XJPX:3649 chart
P/E
21.86
P/S
4.46
EPS
41.26
Div Yield, %
1.17%
Shrs. gr., 5y
-0.29%
Rev. gr., 5y
7.58%
Revenues
5.19b
+14.32%
772,034,0001,144,771,0001,543,160,0001,987,789,0002,382,635,0002,863,916,0002,951,922,0003,288,025,0003,311,714,0003,603,344,0004,281,539,0004,004,859,0004,968,885,0004,541,242,0005,191,735,000
Net income
1.06b
+46.54%
84,893,000193,087,000221,961,000431,877,000517,836,000630,071,000441,399,000499,915,000366,628,000398,015,000499,249,000430,457,000636,027,000722,779,0001,059,140,000
CFO
843m
+21.47%
116,549,000269,618,000171,846,000550,568,000556,521,0001,281,728,000126,962,0001,137,233,000580,488,000597,524,0001,670,010,000542,550,000750,353,000693,848,000842,844,000
Dividend
Dec 27, 20248 JPY/sh

Profile

FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system. It also offers DocuMaker, a document and data management system, which provides various input tools to enhance productivity in document creation; and GAP/GAP-screener, a gaze analyzing perimeter. In addition, the company develops applications for smart phone. It serves medical institutions, hospitals, and clinics. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was founded in 1985 and is headquartered in Tokyo, Japan.
URL
https://findex.co.jp/
IPO date
Mar 23, 2011
Employees
282
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
5,191,735
14.32%
4,541,242
-8.61%
Cost of revenue
1,914,259
1,857,412
Unusual Expense (Income)
NOPBT
3,277,476
2,683,830
NOPBT Margin
63.13%
59.10%
Operating Taxes
463,022
336,210
Tax Rate
14.13%
12.53%
NOPAT
2,814,454
2,347,620
Net income
1,059,140
46.54%
722,779
13.64%
Dividends
(270,494)
(232,020)
Dividend yield
1.02%
1.83%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
(63,092)
Long-term debt
(41,595)
Deferred revenue
38,064
40,375
Other long-term liabilities
278,015
283,842
Net debt
(2,892,290)
(2,575,134)
Cash flow
Cash from operating activities
842,844
693,848
CAPEX
(282,975)
(313,400)
Cash from investing activities
(296,937)
(230,160)
Cash from financing activities
(270,494)
(142,020)
FCF
2,111,992
2,125,523
Balance
Cash
2,693,160
2,413,747
Long term investments
199,130
56,700
Excess cash
2,632,703
2,243,385
Stockholders' equity
5,413,057
4,631,183
Invested Capital
2,528,736
1,791,552
ROIC
130.29%
140.69%
ROCE
63.50%
66.49%
EV
Common stock shares outstanding
25,637
25,617
Price
1,030.00
108.50%
494.00
-50.89%
Market cap
26,406,363
108.66%
12,655,038
-50.88%
EV
23,520,595
10,084,134
EBITDA
3,535,221
2,938,790
EV/EBITDA
6.65
3.43
Interest
448
Interest/NOPBT
0.02%